One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients - Top-Institutions - MDSpire

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

  • By

  • José Luis Piñana

  • Lourdes Vazquez

  • Marisa Calabuig

  • Lucia López-Corral

  • Gabriel Martin-Martin

  • Lucia Villalon

  • Gabriela Sanz-Linares

  • Venancio Conesa-Garcia

  • Andrés Sanchez-Salinas

  • Beatriz Gago

  • Ana Facal

  • Irene Risco-Gálvez

  • María T. Olave

  • Ildefonso Espigado

  • Javier Lopez-Jimenez

  • José Ángel Hernández-Rivas

  • Alejandro Avendaño-Pita

  • Ignacio Arroyo

  • Elena Ferrer

  • Irene García-Cadenas

  • Clara González-Santillana

  • Alicia Roldán-Pérez

  • Blanca Ferrer

  • Manuel Guerreiro

  • María Suarez-Lledó

  • Angela Camara

  • Diana Campos-Beltrán

  • David Navarro

  • Ángel Cedillo

  • Anna Sureda

  • Carlos Solano

  • Rodrigo Martino

  • January 5, 2023

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Infectious Diseases

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Transplantation
    • Infectious Diseases

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Immunology

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Infectious Diseases

  • #5

    Hospital Clinic Barcelona
    Hospital Clinic Barcelona

    Barcelona, Catalonia

    Key Differentiators

    • Hematology
    • Infectious Diseases
    • Transplantation

Original Source(s)

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

  • by José Luis Piñana, Lourdes Vazquez, Marisa Calabuig, Lucia López-Corral, Gabriel Martin-Martin, Lucia Villalon, Gabriela Sanz-Linares, Venancio Conesa-Garcia, Andrés Sanchez-Salinas, Beatriz Gago, Ana Facal, Irene Risco-Gálvez, María T. Olave, Ildefonso Espigado, Javier Lopez-Jimenez, José Ángel Hernández-Rivas, Alejandro Avendaño-Pita, Ignacio Arroyo, Elena Ferrer, Irene García-Cadenas, Clara González-Santillana, Alicia Roldán-Pérez, Blanca Ferrer, Manuel Guerreiro, María Suarez-Lledó, Angela Camara, Diana Campos-Beltrán, David Navarro, Ángel Cedillo, Anna Sureda, Carlos Solano, Rodrigo Martino

  • January 5, 2023

Related Content

Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study

Transforming Treatment for Chronic Lymphocytic Leukemia Patients

Over the past 10 years, the treatment landscape and prognosis for Chronic Lymphocytic Leukemia (CLL) has dramatically improved, even among older adults.

  • June 12, 2025

  • 1 min
Models of autoantibody mediated diseases: actively nearing the human gold standard